Sabra Healthcare - REIT opened at $20.98, in line with its previous close of $20.97. In the last trading session, the stock traded between $20.56 and $21.05. It showed a downward intraday trend.
An investment of $100 made 5 years ago in Sabra Healthcare - REIT is now worth
$ 139.95
Giving a profit of
$ 39.95 (39.95%)
Note: Past profits do not guarantee future returns.
Rating from 8 Analysts
Today's Change
$-0.40 (-1.89%)
Day High
$21.05
Day Low
$20.56
Day Open
$20.98
Prev Close
$20.97
Volume
13,13,303
1W Return
-2.42%
1M Return
7.12%
3M Return
3.62%
6M Return
-0.52%
1Y Return
7.37%
Market Cap ($ Mn)
5,389
PE Ratio
82.44
PB Ratio
1.91
PEG Ratio
97.82
ROE
5.63%
ROCE
5.19%
EPS (TTM)
$0.11
1 Week
-2.42%
1 Month
7.12%
3 Months
3.62%
6 Months
-0.52%
9 Months
4.96%
Sabra Health Care REIT Q3FY26 Results: FFO up 21% to $0.40; guidance raised
Sabra Health Care REIT reported Q3 FFO of $0.40 per share, up 21% YoY from $0.33. Total revenues rose to $249.6 million, driven by strong Senior Housing Operating Portfolio performance. Year-to-date investments totaled $747.2 million, with an additional $425 million in awarded deals. Full-year 2026 FFO guidance raised to $1.145-$1.155 per share, reflecting 7-8% earnings growth. Net debt to adjusted EBITDA ratio improved to 4.54 times, with $1.2 billion in liquidity.
9 days agoSabra Health Care REIT to release Q3 2026 earnings on November 2
Earnings release scheduled for November 2, 2026. Conference call set for November 3 at 10:00 am PT. Webcast and dial-in options available for participants. Digital replay to be hosted on company website.
24 days agoWells Fargo maintains Overweight on Sabra Health Care REIT, cuts target
Wells Fargo analyst James Feldman maintains an Overweight rating on Sabra Health Care REIT. The price target is lowered from $23 to $21. The rating action reflects a revised valuation outlook for the healthcare REIT.
24 days agoSabra Health Care REIT Q2 Revenue Beats Estimates, AFFO Rises to $0.40
Sabra Health Care REIT delivered strong Q2 2026 results with revenue of $235.866 million, surpassing analyst estimates. Normalized AFFO increased to $0.40 per share, supported by 13.7% growth in same-property senior housing Cash NOI, offsetting a GAAP net loss caused by significant loan loss provisions.
3mo agoSabra Health Care REIT FY26 Results: FFO guidance cut to $1.53-$1.55
Sabra Health Care REIT reduced its FY26 FFO guidance to $1.53-$1.55 from $1.55-$1.59. The new range caps at the $1.55 analyst estimate, indicating a cautious outlook. The midpoint drop to $1.54 signals tighter operational expectations for the period.
3mo agoAnalysts raise Sabra Health Care REIT targets to $24, $23
Truist Securities analyst Michael Lewis maintained a Buy rating on Sabra Health Care REIT and increased the price target to $24 from $22, while Baird analyst Wesley Golladay maintained a Neutral rating and raised the target to $23 from $22.
3mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $247.35 | -0.13% | $1,81,458.43M | 106.76 | |
| $130.03 | -0.05% | $1,23,595.21M | 31.27 | |
| $1,068.06 | +1.72% | $1,05,725.12M | 67.21 | |
| $190.24 | -0.07% | $88,226.46M | 24.24 | |
| $234.75 | +0.12% | $75,953.83M | 15.14 | |
| $181.13 | +0.14% | $68,526.19M | 90.03 | |
| $335.73 | -0.06% | $62,728.80M | 29.94 | |
| $59.57 | +0.05% | $56,650.89M | 44.91 | |
| $64.63 | -1.70% | $50,009.34M | 25.14 | |
| $90.42 | +0.09% | $47,815.90M | 170.02 | |
| $89.06 | -0.32% | $37,893.34M | 30.95 | |
| $112.43 | +1.49% | $33,485.48M | 83.86 |
An investment of $100 made 5 years ago in Sabra Healthcare - REIT is now worth
$ 139.95
Giving a profit of
$ 39.95 (39.95%)
Note: Past profits do not guarantee future returns.
